Guozhen Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Guozhen Chen has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Chenguang Ding
Department of Kidney Transplantation, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China
2 shared publications - Wujun Xue
Institute of Organ Transplantation, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China
2 shared publications - Bingxuan Zheng
Department of Kidney Transplantation, Nephropathy Hospital, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China
1 shared publication - Haiping Liu
Organ Procurement and Allocation Organization, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China
1 shared publication - Li Ren
Department of Kidney Transplantation, Hospital of Nephropathy, First Affiliated Hospital of Medical College of Xi’an Jiaotong University, 277 Yanta West Road, Xi’an, Shaanxi Province 710061, China and Institute of Organ Transplantation, Xi’an Jiaotong University, 277 Yanta West Road, Xi’an, Shaanxi Province 710061,China
1 shared publication - Puxun Tian
Department of Kidney Transplantation, Hospital of Nephropathy, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, People’s Republic of China
1 shared publication
Latest Publications
- Open Access
- 6 March 2026
- Published by The Korean Society of Nephrology in Kidney Research and Clinical Practice
Chronic kidney disease in Asia: a meta-analysis
The prevalence of chronic kidney disease (CKD) in Asia was determined by comparing differences in age, sex, area, and analytical methods. This meta-analysis comprised 42 studies with 2,271,169 participants from five databases that were searched until February 30, 2025. The total prevalence of CKD 1-5 was 17.0%, whereas that of stages 3-5 was 7.7% in Asia. Individuals aged >60 years had a higher prevalence rate of CKD 1-5 compared to those aged <60 years. Compared with Asia (as the comparator), the age-standardized prevalence of CKD (aCKD) 1-5 was the highest in Nepal and South Asia, whereas it was the lowest in Vietnam. Compared with the comparator, Vietnam and Malaysia had the highest aCKD 3-5; while, South Korea and India had lower aCKD 3-5. The sex-standardized prevalence of CKD (sCKD) 1-5 was lower in Nepal, Taiwan, Korea, and South Asia and was higher in Bangladesh than in the comparator. The sCKD 3-5 was lowest in Korea and Taiwan and was highest in Iran and Sri Lanka compared with the comparator. Iranian women and men had the highest prevalence of CKD 3-5. South Asia has a higher prevalence of CKD among men and women than East Asia. The prevalence of CKD was greater in the Chronic Kidney Disease Epidemiology Collaboration-based studies than in the Modification of Diet in Renal Disease (MDRD)-based research. The findings indicate that evaluating populations without considering sex and age is difficult, especially when the sex and age of the groups differ greatly.
- 6 March 2026
- Published by The Korean Society of Nephrology in Kidney Research and Clinical Practice
Open AccessChronic kidney disease in Asia: a meta-analysis
The prevalence of chronic kidney disease (CKD) in Asia was determined by comparing differences in age, sex, area, and analytical methods. This meta-analysis comprised 42 studies with 2,271,169 participants from five databases that were searched until February 30, 2025. The total prevalence of CKD 1-5 was 17.0%, whereas that of stages 3-5 was 7.7% in Asia. Individuals aged >60 years had a higher prevalence rate of CKD 1-5 compared to those aged <60 years. Compared with Asia (as the comparator), the age-standardized prevalence of CKD (aCKD) 1-5 was the highest in Nepal and South Asia, whereas it was the lowest in Vietnam. Compared with the comparator, Vietnam and Malaysia had the highest aCKD 3-5; while, South Korea and India had lower aCKD 3-5. The sex-standardized prevalence of CKD (sCKD) 1-5 was lower in Nepal, Taiwan, Korea, and South Asia and was higher in Bangladesh than in the comparator. The sCKD 3-5 was lowest in Korea and Taiwan and was highest in Iran and Sri Lanka compared with the comparator. Iranian women and men had the highest prevalence of CKD 3-5. South Asia has a higher prevalence of CKD among men and women than East Asia. The prevalence of CKD was greater in the Chronic Kidney Disease Epidemiology Collaboration-based studies than in the Modification of Diet in Renal Disease (MDRD)-based research. The findings indicate that evaluating populations without considering sex and age is difficult, especially when the sex and age of the groups differ greatly.
- Open Access
- 18 May 2020
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Access
- Vol. 8, 100497-100508
Prediction of Chronic Kidney Disease Using Adaptive Hybridized Deep Convolutional Neural Network on the Internet of Medical Things Platform
Chronic Kidney disease is a severe lifelong condition caused either by renal disease or by impaired functions of the kidneys. In the present area of research, Kidney cancer is one of the deadliest and crucial importance for the survival of the patients ’ diagnosis and classification. Early diagnosis and proper therapy can stop or delay the development of this chronic disease into the final stage where dialysis or renal transplantation is the only way of saving the life of the patient. The development of automated tools to accurately identify subtypes of kidney cancer is, therefore, an urgent challenge in the recent past. In this paper, to examine the ability of various deep learning methods an Adaptive hybridized Deep Convolutional Neural Network (AHDCNN) has been proposed for the early detection of Kidney disease efficiently and effectively. Classification technology efficiency depends on the role of the data set. To enhance the accuracy of the classification system by reducing the feature dimension an algorithm model has been developed using CNN. These high-level properties help to build a supervised tissue classifier that discriminates between the two types of tissue. The experimental process on the Internet of medical things platform (IoMT)concludes, with the aid of predictive analytics, that advances in machine learning which provides a promising framework for the recognition of intelligent solutions to prove their predictive capability beyond the field of kidney disease.
- 18 May 2020
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Access
- Vol. 8, 100497-100508
Open AccessPrediction of Chronic Kidney Disease Using Adaptive Hybridized Deep Convolutional Neural Network on the Internet of Medical Things Platform
Chronic Kidney disease is a severe lifelong condition caused either by renal disease or by impaired functions of the kidneys. In the present area of research, Kidney cancer is one of the deadliest and crucial importance for the survival of the patients ’ diagnosis and classification. Early diagnosis and proper therapy can stop or delay the development of this chronic disease into the final stage where dialysis or renal transplantation is the only way of saving the life of the patient. The development of automated tools to accurately identify subtypes of kidney cancer is, therefore, an urgent challenge in the recent past. In this paper, to examine the ability of various deep learning methods an Adaptive hybridized Deep Convolutional Neural Network (AHDCNN) has been proposed for the early detection of Kidney disease efficiently and effectively. Classification technology efficiency depends on the role of the data set. To enhance the accuracy of the classification system by reducing the feature dimension an algorithm model has been developed using CNN. These high-level properties help to build a supervised tissue classifier that discriminates between the two types of tissue. The experimental process on the Internet of medical things platform (IoMT)concludes, with the aid of predictive analytics, that advances in machine learning which provides a promising framework for the recognition of intelligent solutions to prove their predictive capability beyond the field of kidney disease.